Blood Clot Retrieval Devices Market: Current Analysis and Forecast (2025-2033)

Global Blood Clot Retrieval Devices Market Size & Forecast

The Global Blood Clot Retrieval Devices Market was valued at USD 1,838.98 million in 2024 and is expected to grow at a strong CAGR of around 14.19% during the forecast period (2025-2033), driven by the rising incidence of ischemic stroke and other thrombotic disorders, increasing awareness and adoption of minimally invasive thrombectomy procedures, and continuous technological advancements in the blood clot retrieval devices.

Blood Clot Retrieval Devices Market Analysis

A blood clot retrieval device refers to medical equipment that helps to eliminate blood clots within the blood vessels and is mainly applied in the treatment of ischemic strokes that are caused by the blockage of the arteries. They are used to repair the normal blood flow to the brain or other areas that may have been damaged, reducing tissue damage and enhancing patient outcomes.

The blood clot retrieval devices market has been increasing because of the increasing number of ischemic strokes, the increased awareness of the advanced management of strokes, and the spread of the use of minimally invasive surgical interventions. The next-generation stent retrievers and aspiration systems have been developed, enhancing treatment outcomes and shortening the recovery period. Additionally, the market is expanding due to favorable government policies, the development of more healthcare facilities, and increased investment in neurovascular studies.

Global Blood Clot Retrieval Devices Market Trends

This section discusses the key market trends that are influencing the various segments of the global Blood Clot Retrieval Devices market, as found by our team of research experts.

Integration of AI-based imaging and navigation systems for precision thrombectomy

The trend of AI-powered imaging and navigation systems in delivering precision thrombectomy is becoming one of the emerging trends in the blood clot retrieval devices market. Artificial intelligence boosts real-time image analysis, which allows for identifying the location, size, and composition of the clot faster and more accurately. These systems help the surgeon plan and execute the procedure more accurately, minimizing complications and maximizing patient health outcomes. The AI-based navigation systems also help in the optimization of workflow efficiently. Moreover, the integration of AI in the process of thrombectomy is transforming stroke management and enhancing the performance of blood clot retrieval devices as healthcare providers are becoming more digital and technologically advanced.

Blood Clot Retrieval Devices Industry Segmentation

This section provides an analysis of the key trends in each segment of the global Blood Clot Retrieval Devices market report, along with forecasts at the global, regional, and country levels for 2025-2033.

The Ischemic Stroke Segment Dominates the Global Blood Clot Retrieval Devices Market

Based on stroke type category, the market is categorised into ischemic stroke, hemorrhagic stroke, and transient ischemic attack. Among these, the ischemic stroke holds the maximum market share. The high prevalence of ischemic stroke, which is caused by the obstruction of blood flow by the formation of clots, has created a great demand for thrombectomy procedures with the use of stent retrievers and aspiration devices. In addition, robust clinical data available in support of mechanical thrombectomy as the standard treatment of ischemic stroke have also contributed to the growth of this segment. However, the transient ischemic attack is projected to experience robust growth in the future due to increasing awareness, improved diagnostic capabilities, and early intervention strategies aimed at preventing full-scale ischemic strokes.

The Stent Retrievers Dominates the Global Blood Clot Retrieval Devices Market.

Based on the device type category, the market is categorized into stent retrievers, aspiration devices, mechanical thrombectomy devices, and others. Among these, stent retrievers have the largest market share, due to the demonstrated clinical effectiveness, accuracy in removing clots, and universal use as the gold standard of treating large vessel occlusions during ischemic stroke. For instance, according to the Radiological Society of North America, stent retrievers act as an efficient device to treat ischemic strokes. The devices are associated with high recanalization rates, decreased procedure time, and increased patient health outcomes, which is why they are very popular among neuro-interventionalists. Major companies like Stryker, Medtronic, and Johnson & Johnson have a established stent retriever portfolios that further strengthen the dominance of this segment. However, the most rapid growth is likely to be seen in aspiration devices due to innovations in aspiration catheter design, the increasing popularity of minimally invasive forms of a direct aspiration first-pass technique (ADAPT), and decreasing procedure costs.

North America holds the largest market share in the global Blood Clot Retrieval Devices market

The blood clot retrieval devices market was dominated by North America with its well-developed healthcare facilities, high prevalence of ischemic strokes, and early adoption of advanced medical devices. The region has good reimbursement policies, higher spending on healthcare, and a high level of access to qualified specialists who carry out neurovascular operations. Also, the existence of major market participants, efficient product innovations, and strong clinical research efforts is an added advantage to market growth. Increased awareness regarding timely stroke treatment and government programs that reinforce the use of stroke care also act as contributing factors in making the region a market leader in the blood clot retrieval devices market.

The United States held a Dominant share of the North America Blood Clot Retrieval Devices Market in 2024

The United States is a dominant player in the North America blood clot retrieval devices market because of its technological progress rate, significant spending on the healthcare system, and the presence of a large proportion of clinical users of next-generation thrombectomy systems. Additionally, there is a growing cases of blood clots in this country, which drives the demand for blood clot retrieval devices. According to the WHO, nearly 900,000 people in the United States are diagnosed with problematic blood clots in the venous system every year, leading to between 60,000 and 100,000 deaths annually. Due to this, there is an increase in stroke-specific hospitals and the availability of properly organized training of interventional neurologists, which has increased the use of these devices. A close partnership between hospitals, research centers, and medical equipment manufacturers has helped speed up product development and clinical testing. Moreover, patient education about stroke symptoms and the quicker availability of emergency medical services through better networks of hospitals have contributed greatly to the rates of treatment, making the United States the dominant country in the North America market.

Blood Clot Retrieval Devices Industry Competitive Landscape

The global blood clot retrieval devices market is competitive, with several global and international market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, geographical expansions, and mergers and acquisitions.

Top Blood Clot Retrieval Devices Market Companies

Some of the major players in the market are Johnson & Johnson, Abbott Laboratories, Stryker, Medtronic Plc, Terumo Corporation, Penumbra, Inc., Boston Scientific Corporation, Argon Medical Devices, Inc., AngioDynamics, Inc., and Zylox-Tonbridge Medical Technology Co., Ltd.

Recent Developments in the Blood Clot Retrieval Devices Market

• In July 2025, Inari Medical, which is now a part of Stryker, announced the launch of its next-generation InThrill Thrombectomy System, which is the first and only purpose-built small vessel and arteriovenous (AV) access thrombectomy system that can deliver fast, full luminal clot removal.

• In April 2024, Penumbra, Inc., the world’s largest thrombectomy company, announced the U.S. Food and Drug Administration (FDA) clearance and launch of Lightning Flash™ 2.0, which is the next-generation computer-assisted vacuum thrombectomy (CAVT) system to remove venous thrombus and treat pulmonary emboli (PE).

Global Blood Clot Retrieval Devices Market Report Coverage

Reasons to Buy the Blood Clot Retrieval Devices Market Report:

• The study includes market sizing and forecasting analysis confirmed by authenticated key industry experts.

• The report briefly reviews overall industry performance at a glance.

• The report covers an in-depth analysis of prominent industry peers, primarily focusing on key business financials, type portfolios, expansion strategies, and recent developments.

• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

• The study comprehensively covers the market across different segments.

• Deep dive regional level analysis of the industry.

Customization Options:

The Global Blood Clot Retrieval Devices Market can further be customized as per the requirements or any other market segment. Besides this, UnivDatos understands that you may have your own business needs; hence, feel free to contact us to get a report that completely suits your requirements.